Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority to DO2003000733ApriorityCriticalpatent/DOP2003000733A/en
Publication of DOP2003000733ApublicationCriticalpatent/DOP2003000733A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems
(AREA)
Abstract
Se describen compuestos de hidroxamatos bicíclicos representados por la fómula I Los compuestos de hidroxamato bicíclicos uy las composicione que contienen estos compuestos pueden ser usados para inhibir o modular una actividad enzimática de HIV integrasa y para tratar enfermedades y estados mediados por HIV.Compounds of bicyclic hydroxamates represented by the formula I are described. The bicyclic hydroxamate compounds and the compositions containing these compounds can be used to inhibit or modulate an enzymatic activity of HIV integrase and to treat diseases and conditions mediated by HIV.
DO2003000733A2003-10-102003-10-10
HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
DOP2003000733A
(en)